STOCK TITAN

Quanterix (NASDAQ: QTRX) director receives stock and RSU awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Quanterix Corp director Scott Mendel reported new equity awards in the company’s stock. On 01/02/2026, he received 23,372 restricted stock units that will vest in full on January 2, 2027 under the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy, with each unit representing one share of common stock. On the same date, he was also granted 1,944 shares of common stock issued in lieu of cash fees for his Board and committee service for the fourth quarter of 2025. Following these awards, he beneficially owned 56,053 shares of Quanterix common stock, including 47,836 restricted stock units, all reported as directly held.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mendel Scott

(Last) (First) (Middle)
C/O QUANTERIX CORPORATION
900 MIDDLESEX TURNPIKE

(Street)
BILLERICA MA 01821

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Quanterix Corp [ QTRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/02/2026 A 23,372(1) A $0.00 54,109(2) D
Common Stock 01/02/2026 A 1,944(3) A $0.00 56,053(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units that vest as to 100% of the shares on January 2, 2027 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
2. Includes 47,836 restricted stock units.
3. Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2025.
Remarks:
/s/ Bonnie McManus, Attorney-in-Fact 01/06/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Quanterix (QTRX) director Scott Mendel report?

Scott Mendel reported two equity awards effective 01/02/2026: 23,372 restricted stock units and 1,944 shares of Quanterix common stock, both reported at a price of $0.00 per share.

What are the terms of the 23,372 restricted stock units reported by Quanterix (QTRX) director Scott Mendel?

The 23,372 restricted stock units vest as to 100% of the shares on January 2, 2027, granted under the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy, and each unit represents one share of common stock.

Why did Quanterix (QTRX) grant 1,944 shares of common stock to director Scott Mendel?

The 1,944 shares of common stock consist of stock granted in lieu of cash fees for Scott Mendel’s service on Quanterix’s Board of Directors and its committees for the fourth quarter of 2025.

How many Quanterix (QTRX) shares does Scott Mendel beneficially own after these transactions?

After the reported transactions, Scott Mendel beneficially owned 56,053 shares of Quanterix common stock, which includes 47,836 restricted stock units.

Are Scott Mendel’s Quanterix (QTRX) holdings reported as directly or indirectly owned?

The filing reports Scott Mendel’s 56,053 beneficially owned shares of Quanterix common stock, including restricted stock units, as directly held.

What price per share was reported for Scott Mendel’s Quanterix (QTRX) equity awards?

Both the 23,372 restricted stock units and the 1,944 shares of Quanterix common stock were reported with a transaction price of $0.00 per share.

Quanterix

NASDAQ:QTRX

View QTRX Stock Overview

QTRX Rankings

QTRX Latest News

QTRX Latest SEC Filings

QTRX Stock Data

223.43M
41.21M
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA